This study is to verify the efficacy of fluvoxamine maleate given for 10 weeks in treatment
of children and adolescents with obsessive-compulsive disorder
Minimum age: 8 Years.
Maximum age: 18 Years.
Gender(s): Both.
Site 1, Hokkaido, Japan; Recruiting
Site 2, Chiba, Japan; Recruiting
Site 3, Tokyo, Japan; Recruiting
Site 4, Kanazawa, Japan; Recruiting
Site 5, Mie, Japan; Recruiting
Site 6, Nara, Japan; Recruiting
Site 7, Kyoto, Japan; Recruiting
Site 8, Kagawa, Japan; Recruiting
Site 9, Fukuoka, Japan; Recruiting
Site 10, Kumamoto, Japan; Completed
Site 11, Osaka, Japan; Recruiting
Site 12, Osaka, Japan; Recruiting
Site 13, Tokushima, Japan; Recruiting
Site 14, Fukuoka, Japan; Recruiting
Site 15, Tokyo, Japan; Recruiting
Site 16, Nagoya, Japan; Recruiting
Site 17, Kanagawa, Japan; Recruiting
Site 18, Fukushima, Japan; Recruiting
Site 19, Fukuoka, Japan; Recruiting
Site 20, Mie, Japan; Recruiting
Site 21, Hyogo, Japan; Recruiting
Site 22, Tokyo, Japan; Withdrawn
Site 23, Nagano, Japan; Recruiting
Site 24, Nagoya, Japan; Recruiting
Site 25, Kanagawa, Japan; Recruiting
Site 26, Hiroshima, Japan; Recruiting
Site 27, Hokkaido, Japan; Recruiting
Site 28, Gunma, Japan; Recruiting
Site 29, Nagoya, Japan; Recruiting
Site 30, Osaka, Japan; Recruiting
Site 31, Tokyo, Japan; Recruiting
Site 32, Tochigi, Japan; Recruiting
Site 33, Hyogo, Japan; Recruiting
Site 34, Nagano, Japan; Recruiting
Site 35, Hyogo, Japan; Recruiting
Site 36, Oita, Japan; Recruiting